These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33915379)

  • 1. Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one month.
    Singh AK; Verma RK; Mukker JK; Yadav AB; Muttil P; Sharma R; Mohan M; Agrawal AK; Gupta A; Dwivedi AK; Gupta P; Gupta UD; Mani U; Chaudhari BP; Murthy RC; Sharma S; Bhadauria S; Singh S; Rath SK; Misra A
    Tuberculosis (Edinb); 2021 May; 128():102081. PubMed ID: 33915379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis.
    Verma RK; Agrawal AK; Singh AK; Mohan M; Gupta A; Gupta P; Gupta UD; Misra A
    Tuberculosis (Edinb); 2013 Jul; 93(4):412-7. PubMed ID: 23562366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalable Particles for "Pincer Therapeutics" Targeting Nitazoxanide as Bactericidal and Host-Directed Agent to Macrophages in a Mouse Model of Tuberculosis.
    Gupta A; Meena J; Sharma D; Gupta P; Gupta UD; Kumar S; Sharma S; Panda AK; Misra A
    Mol Pharm; 2016 Sep; 13(9):3247-55. PubMed ID: 27463245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and Preclinical Evaluation of Inhalable Particles Containing Rapamycin and Anti-Tuberculosis Agents for Induction of Autophagy.
    Gupta A; Sharma D; Meena J; Pandya S; Sachan M; Kumar S; Singh K; Mitra K; Sharma S; Panda AK; Gupta P; Gupta UD; Misra A
    Pharm Res; 2016 Aug; 33(8):1899-912. PubMed ID: 27095353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalable locust bean gum microparticles co-associating isoniazid and rifabutin: Therapeutic assessment in a murine model of tuberculosis infection.
    Grenha A; Alves AD; Guerreiro F; Pinho J; Simões S; Almeida AJ; Gaspar MM
    Eur J Pharm Biopharm; 2020 Feb; 147():38-44. PubMed ID: 31790800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination.
    Chuang YM; Dutta NK; Gordy JT; Campodónico VL; Pinn ML; Markham RB; Hung CF; Karakousis PC
    Front Immunol; 2020; 11():680. PubMed ID: 32411131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial biodistribution and pharmacokinetics of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to rhesus macaques.
    Kumar Verma R; Mukker JK; Singh RS; Kumar K; Verma PR; Misra A
    Mol Pharm; 2012 Apr; 9(4):1011-6. PubMed ID: 22397370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of rifabutin alone or in combination with isoniazid in preventive therapy of mouse tuberculosis.
    Jabès D; Della Bruna C; Rossi R; Olliaro P
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2346-50. PubMed ID: 7840568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
    Pandey R; Sharma A; Zahoor A; Sharma S; Khuller GK; Prasad B
    J Antimicrob Chemother; 2003 Dec; 52(6):981-6. PubMed ID: 14613962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic Adjuvant 4-Hexylresorcinol Enhances the Efficiency of Antituberculosis Drugs.
    Nikolaev YA; Mukhina TN; Potapov VD; Kuznetsov BB; El'-Registan GI; Firstova VV; Shemyakin IG; Manzenyuk OY
    Bull Exp Biol Med; 2024 Feb; 176(4):466-471. PubMed ID: 38488964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhalable microparticles containing isoniazid and rifabutin target macrophages and 'stimulate the phagocyte' to achieve high efficacy.
    Yadav AB; Sharma R; Muttil P; Singh AK; Verma RK; Mohan M; Patel SK; Misra A
    Indian J Exp Biol; 2009 Jun; 47(6):469-74. PubMed ID: 19634713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of apoptosis of THP-1 cells infected with Mycobacterium tuberculosis by inhalable microparticles and relevance to bactericidal activity.
    Yadav AB; Misra A
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3740-2. PubMed ID: 17664326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis.
    Weiner M; Benator D; Burman W; Peloquin CA; Khan A; Vernon A; Jones B; Silva-Trigo C; Zhao Z; Hodge T;
    Clin Infect Dis; 2005 May; 40(10):1481-91. PubMed ID: 15844071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant Tuberculosis.
    Verma S; Dal NK; Srivastava A; Bharti R; Siva Reddy DV; Sofi HS; Roy T; Verma K; Raman SK; Azmi L; Ray L; Mugale MN; Singh AK; Singh J; Griffiths G; Misra A
    AAPS PharmSciTech; 2023 Jun; 24(5):130. PubMed ID: 37291443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient, inhaled gene therapy with gamma interferon mitigates pathology induced by host response in a mouse model of tuberculosis.
    Bharti R; Roy T; Verma S; Reddy DVS; Shafi H; Verma K; Raman SK; Pal S; Azmi L; Singh AK; Ray L; Mugale MN; Misra A
    Tuberculosis (Edinb); 2022 May; 134():102198. PubMed ID: 35344918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice.
    Verma RK; Kaur J; Kumar K; Yadav AB; Misra A
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3195-201. PubMed ID: 18591268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs.
    Dutta NK; Illei PB; Peloquin CA; Pinn ML; Mdluli KE; Nuermberger EL; Grosset JH; Karakousis PC
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3726-31. PubMed ID: 22547623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of twice-weekly rifabutin-isoniazid combinations versus daily isoniazid for latent tuberculosis in HIV-infected subjects: a pilot study.
    Matteelli A; Olliaro P; Signorini L; Cadeo G; Scalzini A; Bonazzi L; Caligaris S; Tomasoni L; Tebaldi A; Carosi G
    Int J Tuberc Lung Dis; 1999 Nov; 3(11):1043-6. PubMed ID: 10587327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
    Ahmad Z; Nuermberger EL; Tasneen R; Pinn ML; Williams KN; Peloquin CA; Grosset JH; Karakousis PC
    J Antimicrob Chemother; 2010 Apr; 65(4):729-34. PubMed ID: 20123722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infection.
    Cynamon MH; Zhang Y; Harpster T; Cheng S; DeStefano MS
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2922-4. PubMed ID: 10582883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.